1. Transfusion in Head and Neck Cancer Patients Undergoing Pedicled Flap Reconstruction
- Author
-
Sidharth V. Puram, Sumi Sinha, Daniel G. Deschler, Neerav Goyal, Derrick T. Lin, Rosh K. V. Sethi, Nicholas B. Abt, and Kevin S. Emerick
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Fistula ,Island Flaps ,Perioperative ,Free flap ,Pedicled Flap ,Dehiscence ,Hematocrit ,medicine.disease ,Surgery ,03 medical and health sciences ,0302 clinical medicine ,Otorhinolaryngology ,Blood product ,Medicine ,030223 otorhinolaryngology ,business ,030217 neurology & neurosurgery - Abstract
OBJECTIVE Blood product utilization is monitored to prevent unnecessary transfusions. Head-and-neck pedicled flap reconstruction transfusion-related outcomes were assessed. METHODS One hundred and thirty-six pedicled flap patients were reviewed: 64 supraclavicular artery island flaps (SCAIF), 57 pectoralis major (PM) flaps, and 15 submental (SM) flaps. Outcome parameters included flap-related complications, medical complications, length of stay (LOS), and flap survival. Multivariable logistic regression analyses were performed. Multivariable logistic regression analyses were performed to adjust for relevant pre- and perioperative factors. RESULTS Of all head-and-neck pedicled flap patients included in our analyses (n = 136), 40 (29.4%) received blood transfusions. The average pretransfusion hematocrit (Hct) was 24.3% ± 0.5%, with 2.65 ± 0.33 units transfused and a posttransfusion Hct increase of 5.0% ± 0.6%. Transfusion rates differed with PM (47.4%), SCAIF (17.2%), and SM (13.3%) flaps (P
- Published
- 2018
- Full Text
- View/download PDF